- $562.27m
- $523.24m
- $111.06m
- 86
- 29
- 58
- 59
Annual income statement for OTC Markets, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PRESS | PRESS | PRESS | PRESS | PRESS |
| Standards: | — | — | — | — | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 71.2 | 103 | 105 | 110 | 111 |
| Cost of Revenue | |||||
| Gross Profit | 65.4 | 90.6 | 96.2 | 101 | 101 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 49.8 | 64.9 | 68.3 | 77.3 | 78.9 |
| Operating Profit | 21.4 | 38 | 36.8 | 32.6 | 32.2 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 21.4 | 38 | 37 | 33.5 | 33.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 18.3 | 30.5 | 30.8 | 27.7 | 27.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 18.3 | 30.5 | 30.8 | 27.7 | 27.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 18.3 | 30.5 | 30.8 | 27.7 | 27.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.57 | 2.58 | 2.59 | 2.33 | 2.31 |
| Dividends per Share | |||||
| Special Dividends per Share |